BIOMAT Database Logo BIOMAT Database Logo

Clinical experience with a single silastic implant-D containing norethindrone acetate in a Bombay hospital. 1978

A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007436 Intrauterine Devices, Medicated Intrauterine devices that release contraceptive agents. Hormone-Releasing IUDs,IUD, Hormone Releasing,Intrauterine Devices, Hormone-Releasing,Intrauterine Devices, Progesterone-Releasing,Medicated Intrauterine Devices,Device, Hormone-Releasing Intrauterine,Device, Medicated Intrauterine,Device, Progesterone-Releasing Intrauterine,Devices, Hormone-Releasing Intrauterine,Devices, Medicated Intrauterine,Devices, Progesterone-Releasing Intrauterine,Hormone Releasing IUD,Hormone-Releasing IUD,Hormone-Releasing Intrauterine Device,Hormone-Releasing Intrauterine Devices,IUD, Hormone-Releasing,IUDs, Hormone-Releasing,Intrauterine Device, Hormone-Releasing,Intrauterine Device, Medicated,Intrauterine Device, Progesterone-Releasing,Intrauterine Devices, Hormone Releasing,Intrauterine Devices, Progesterone Releasing,Medicated Intrauterine Device,Progesterone-Releasing Intrauterine Device,Progesterone-Releasing Intrauterine Devices
D007722 Health Knowledge, Attitudes, Practice Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL). Knowledge, Attitudes, Practice
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005193 Family Planning Services Health care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths. Family Planning,Family Planning Programs,Planned Pregnancy,Pregnancy, Planned,Family Planning Program,Family Planning Service,Planned Pregnancies,Planning Service, Family,Planning Services, Family,Pregnancies, Planned,Program, Family Planning,Programs, Family Planning,Service, Family Planning,Services, Family Planning
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation.
April 1978, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Local tissue response to silastic implant containing norethindrone acetate in women.
January 1977, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Effect of a subdermal silastic implant containing norethindrone acetate on human lactation.
October 1977, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate.
December 1978, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Circulating levels of norethindrone in women with a single silastic implant.
April 1978, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate.
April 1977, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
February 1982, Acta endocrinologica,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
May 1975, Contraception,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Clinical evaluation of interval contraception by norethindrone acetate implant.
October 1982, The Indian journal of medical research,
A Mandlekar, and P N Anandalaxmi, and U R Krishna, and V Mhatre, and C M Alwani, and V N Purandare, and H S Yadava, and K R Laumas
Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
February 1981, Contraception,
Copied contents to your clipboard!